Our product range includes a wide range of merogril 1 gm - meropenem injection ip and cefoking 1.5 gm - cefoperazone & sulbactam for injection.
₹ 270 / Vial Get Latest Price
| Strength | 1 gm |
| Pack Size | 10 ml |
| Pack Type | Vial |
| Brand Name | MEROGRIL - 1GM |
| Manufacturer | SUNRIA BIOSCIENCE LLP |
| Prescription/Non Prescription | Prescription |
| Shelf Life | 24 months from the date of manufacturing |
| Also Gives | Third Party Manufacturing |
| Country of Origin | Made in India |
Minimum order quantity: 100 Vial
MEROGRIL 1 GM is a high-quality Meropenem Injection IP designed to provide fast-acting and broad-spectrum antibacterial action. Manufactured under stringent GMP-certified conditions, MEROGRIL 1 GM is trusted by healthcare professionals for the treatment of severe bacterial infections in hospitals and clinical settings.
This sterile injectable is ideal for managing a wide range of infections, including complicated skin, intra-abdominal, and urinary tract infections. It offers reliable efficacy against both Gram-positive and Gram-negative bacteria, making it a preferred choice in critical care.
Core Features & Benefits
Broad-Spectrum Efficacy: Targets aerobic and anaerobic bacteria, ensuring comprehensive antimicrobial coverage.
Rapid Onset: Delivers peak plasma concentrations within minutes, facilitating prompt therapeutic action in severe infections.
High Stability: Lyophilized formulation ensures extended shelf life (up to 24 months), maintaining potency under controlled storage conditions.
IP‑Certified Quality: Manufactured in an ISO‑certified facility, fully compliant with Indian Pharmacopoeia guidelines.
Patient Safety: Low risk of nephrotoxicity and hepatotoxicity compared to alternative carbapenems.
Quality Assurance
Our GMP‑certified manufacturing processes include:
Raw Material Validation: Comprehensive identity and purity testing of active pharmaceutical ingredients.
In-Process Controls: Real‑time monitoring of pH, sterility, and particulate count.
Final Release Testing: Conformity to IP monograph for assay, sterility, endotoxin levels, and dissolution profile.
Batch Traceability: Full documentation for seamless regulatory audits and pharmacovigilance.
Why Partner with Satcure Bioscience?
Dedicated Pharma Sales Support: 24/7 account management and responsive customer service.
Competitive MOQ & Pricing: Flexible minimum order quantities and tiered pricing for bulk procurement.
Regulatory Expertise: Assistance with product registration, import permits, and dossier preparation.
On‑Time Delivery: Robust logistics network ensuring prompt dispatch and real‑time shipment tracking.
For detailed quotations, technical dossiers, and sample requests, please contact our Pharma Sales Division.
₹ 75 / Piece Get Latest Price
| Packaging Size | 1.5 gm |
| Also gives | Third Party Manufacturing |
| Packaging Type | Vial |
| Shelf life | 24 months |
| Form | Injection |
| Country of Origin | Made in India |
Minimum order quantity: 200 Piece
CEFOKING 1.5 GM is a high-quality Cefoperazone and Sulbactam for Injection offered by Satcure Bioscience, manufactured under strict GMP-WHO guidelines. This broad-spectrum antibiotic combination is specially formulated to treat a wide range of bacterial infections, ensuring fast recovery and optimal clinical outcomes.
This formulation contains Cefoperazone 1 gm and Sulbactam 0.5 gm, and is used for treating moderate to severe infections including respiratory tract infections, urinary tract infections (UTIs), skin infections, abdominal infections, and septicemia.
Broad‑Spectrum Efficacy: Targets resistant organisms including Pseudomonas aeruginosa, E. coli, Klebsiella spp., and Staphylococcus spp.
β‑Lactamase Protection: Sulbactam component safeguards Cefoperazone from enzymatic breakdown, ensuring sustained activity.
Rapid Onset: Fast‑acting IV/IM administration promotes quick bactericidal action.
USP‑Certified Quality: Manufactured under stringent GMP conditions; complies with international pharmacopoeia standards.
Low Pyrogenicity: Rigorous endotoxin testing guarantees patient safety.
CEFOKING 1.5 GM is recommended for treatment of:
Severe lower respiratory tract infections (e.g., pneumonia)
Complicated urinary tract infections
Intra‑abdominal sepsis
Skin, soft tissue, and bone infections
Febrile neutropenia in oncology settings
Reliable Supply Chain: On‑time delivery across pan‑India distribution network.
Competitive Pricing: Optimized for institutional and bulk hospital procurement.
Technical Support: Dedicated medical affairs team for product training and queries.
Regulatory Compliance: Licenses approved by CDSCO and state drug authorities.
Ayush Thakkar (Owner)
Satcure Bioscience LLP
A-503, Money Plant High Street, NR. Bsnl Office, Jagatpur Road, Jagatpur
Ahmedabad - 382470, Gujarat, India